Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBQLN1 antisense RNA 1 (UBQLN1-AS1)
- Target
- UBQLN1-AS1
- Molecular classification
- Long non-coding RNA, Antisense RNA
01
Overview
UBQLN1 antisense RNA 1 (UBQLN1-AS1) is a non-coding antisense transcript overlapping the UBQLN1 locus[6]. Like other antisense RNAs, it may regulate the expression of its sense partner gene UBQLN1 in cis (where the RNA or its transcription affects the same chromosome) or in trans through RNA-mediated mechanisms, such as interference with transcription, chromatin remodeling, or RNA stability[3]. The general roles of antisense RNAs involve modulating gene expression, sometimes contributing to imprinting and cell differentiation, but the specific biological functions and disease implications of UBQLN1-AS1 remain largely uncharacterized in current publicly available sources[3]. No therapeutics or direct drug interactions are presently known for UBQLN1-AS1, and it is not considered a classical therapeutic target such as a receptor, enzyme, transporter, or ion channel.
- Other names
- UBQLN1-AS1
02
Mechanism of action
N/A (No drugs known to target UBQLN1-AS1)
03
Biological functions
Regulation of gene expression (through antisense mechanisms)Epigenetic regulationPotential involvement in transcriptional interference or chromatin modification
04
Disease associations
Direct roles not clearly established for UBQLN1-AS1; however, antisense RNA in general is implicated in cancer, imprinting disorders, and gene expression diseases
05
Safety considerations
None known or established
06
Interacting drugs
None known or established
07
Biomarkers
None known or established
Beyond the preview
Go deeper on UBQLN1 antisense RNA 1 (UBQLN1-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on UBQLN1 antisense RNA 1 (UBQLN1-AS1).